Urology · Gadsden, AL
NPI
1033167465
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
713 Goodyear Ave
Gadsden, AL, 35903
Phone (256) 492-4040
Groups this clinician bills Medicare through
Medicare paid, 2024
$296K
89,846 services
Medicare patients, 2024
620
Average age 75
Drug cost, 2024
$704K
3,447 prescriptions
Company payments, 2025
$913
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Merle L Wade Jr. was code J1071 (injection, testosterone cypionate, 1 mg), 77,420 times for 31 patients. In total Merle L Wade Jr. billed 89,846 services in 98 codes, and Medicare paid $296K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 77,420 | 31 | $0.02 | $1,376 |
| 84311 Immunoassay | Office | 1,192 | 337 | $7.88 | $9,391 |
| 99214 Office E&M - Established | Office | 766 | 412 | $83.15 | $64K |
| 84156 Clinical Chemistry | Office | 598 | 337 | $3.57 | $2,137 |
| 83069 Blood Count | Office | 597 | 337 | $3.84 | $2,292 |
| 82945 Clinical Chemistry | Office | 597 | 337 | $3.82 | $2,280 |
| 84580 Clinical Chemistry | Office | 596 | 337 | $9.29 | $5,534 |
| 82010 Clinical Chemistry | Office | 596 | 337 | $7.94 | $4,730 |
| 82247 Clinical Chemistry | Office | 596 | 337 | $4.88 | $2,909 |
| 81007 Clinical Chemistry | Office | 594 | 336 | $29.11 | $17K |
| 82043 Clinical Chemistry | Office | 584 | 335 | $5.62 | $3,279 |
| 96372 Injection Administration | Office | 543 | 33 | $9.31 | $5,053 |
| 81003 Clinical Chemistry | Office | 518 | 269 | $2.18 | $1,129 |
| 36415 Venipuncture Blood Collection | Office | 477 | 294 | $7.84 | $3,738 |
| 84153 Clinical Chemistry | Office | 430 | 288 | $17.91 | $7,702 |
By year: 2022 $297K for 93,107 services; 2023 $262K for 91,991 services; 2024 $296K for 89,846 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 84311 Immunoassay | 1,192 | 337 | $7.88 | $9,391 |
| 84156 Clinical Chemistry | 598 | 337 | $3.57 | $2,137 |
| 83069 Blood Count | 597 | 337 | $3.84 | $2,292 |
| 82945 Clinical Chemistry | 597 | 337 | $3.82 | $2,280 |
| 82010 Clinical Chemistry | 596 | 337 | $7.94 | $4,730 |
| 84580 Clinical Chemistry | 596 | 337 | $9.29 | $5,534 |
| 82247 Clinical Chemistry | 596 | 337 | $4.88 | $2,909 |
| 81007 Clinical Chemistry | 594 | 336 | $29.11 | $17K |
| 82043 Clinical Chemistry | 584 | 335 | $5.62 | $3,279 |
| 81003 Clinical Chemistry | 518 | 269 | $2.18 | $1,129 |
Medicare prescription drug claims, 2024
In 2024, the drug Merle L Wade Jr. prescribed most often to Medicare patients was Tamsulosin Hcl, with 846 prescriptions and refills. In total Merle L Wade Jr. wrote 3,447 Medicare prescriptions that cost $704K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 846 | 1,580 | 217 | $11K |
| Finasteride Generic | 429 | 825 | 98 | $5,496 |
| Cephalexin Generic | 347 | 373 | 170 | $1,353 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 311 | 464 | 73 | $5,590 |
| Myrbetriq Mirabegron | 241 | 284 | 37 | $114K |
| Ciprofloxacin Hcl Generic | 203 | 203 | 144 | $774 |
| Gemtesa Vibegron | 134 | 164 | 29 | $75K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 127 | 127 | 109 | $314 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 93 | 111 | 27 | $1,993 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 90 | 92 | 71 | $1,422 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 60 | 60 | 56 | $190 |
| Dutasteride Generic | 52 | 98 | 11 | $1,819 |
| Potassium Citrate Er Potassium Citrate | 47 | 53 | Under 11 | $3,432 |
| Trimethoprim Generic | 41 | 45 | Under 11 | $1,406 |
| Levofloxacin Generic | 37 | 37 | 33 | $155 |
Brand drugs: 485 claims; generic drugs: 2,962 claims; opioid claims: 144.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Merle L Wade Jr. $913 ($913 in general payments such as food, travel and fees) from 17 companies. The largest payer was Sumitomo Pharma America, Inc. with $254.
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. 4506.T | 15 | $254 |
| Ferring Pharmaceuticals Inc. | 8 | $164 |
| Astellas Pharma US Inc 4503.T | 5 | $90.67 |
| Janssen Biotech, Inc. JNJ | 4 | $73.04 |
| Medtronic, Inc. MDT | 1 | $43.68 |
| Accord Healthcare, Inc. | 1 | $42.88 |
| Urogen Pharma, Inc. URGN | 2 | $41.35 |
| Olympus America Inc. | 2 | $40.53 |
| Kerecis Limited | 1 | $28.81 |
| Blue Earth Diagnostics | 1 | $23.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.